CON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock today.", "Buy now: the stock is in a clean bullish trend (SMA_5 > SMA_20 > SMA_200) with a strengthening MACD, and fundamentals/news flow are supportive (FY25 up, FY26 growth guide).", "Momentum is stretched (RSI_6 ~76.8 and price above R2), so near-term consolidation is likely, but the prevailing trend and guidance-driven sentiment still favor upside into the next few weeks.", "Key levels to watch: upside continuation is supported while price holds above ~22.6 (prior R1 area)."]
["Trend: Bullish structure with stacked moving averages (SMA_5 > SMA_20 > SMA_200), indicating sustained upward momentum.", "MACD: Histogram +0.0938 and expanding above zero \u2192 bullish acceleration still intact.", "RSI: RSI_6 at 76.805 (overbought/extended) \u2192 higher chance of short-term cooling, not a trend break by itself.", "Support/Resistance: Pivot 22.001; current price 23.5 is above R2 (22.996) \u2192 breakout/extension zone; nearest practical support zones are ~23.0 then ~22.6 and ~22.0.", "Quant-style pattern read: Similar-pattern stats imply mild near-term drift (-0.71% next day, -0.51% next week) but positive 1-month bias (+3.78%)."]
["Guidance catalyst: FY26 revenue guide $2.25B\u2013$2.35B and Adj. EBITDA $450M\u2013$470M supports a growth narrative.", "FY25 outlook: Expected FY25 revenue $2.1634B (+13.9% YoY) with record patient visits (>13.5M) \u2192 strong operating momentum.", "Upcoming event: QDEC 2025 earnings on 2026-02-26 (after hours) can act as a sentiment/volatility catalyst if results align with guidance."]
["Technicals are extended: RSI is high and price is above R2, which often precedes short-term pullbacks or sideways digestion.", "Options imply large move expectations: Elevated IV increases the market\u2019s sensitivity to any guidance nuance at the upcoming earnings release.", "No notable supportive accumulation signals from tracked flows: hedge fund and insider trend indicators are neutral."]
["Latest reported quarter: 2025/Q3.", "Revenue: $572.8M, up 16.98% YoY (strong top-line growth trend).", "Net income: $47.686M, up 7.55% YoY (profit growth, though slower than revenue).", "EPS: $0.37, flat YoY (suggests share count/expenses may be offsetting some operating gains).", "Gross margin: 25.73%, up 2.14% YoY (margin trend improving)."]
["Recent trend: Net positive\u2014RBC Capital (2026-02-02) raised price target to $31 from $30 and reiterated Outperform, citing above-consensus Q4 pre-announcement and initial FY26 guide.", "Wall Street pro view (pros): Stability/resilience of the model even with macro uncertainty; guidance visibility supports continued rerating potential.", "Wall Street pro view (cons): Limited breadth of recent coverage in the provided data; the other listed notes appear to reference a different company (Continental AG), so they are not actionable for CON."]
